Matches in Wikidata for { <http://www.wikidata.org/entity/Q98216077> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q98216077 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98216077 description "scientific article published on 01 August 2020" @default.
- Q98216077 description "wetenschappelijk artikel" @default.
- Q98216077 description "наукова стаття, опублікована 1 серпня 2020" @default.
- Q98216077 name "Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction" @default.
- Q98216077 name "Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction" @default.
- Q98216077 type Item @default.
- Q98216077 label "Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction" @default.
- Q98216077 label "Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction" @default.
- Q98216077 prefLabel "Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction" @default.
- Q98216077 prefLabel "Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction" @default.
- Q98216077 P1433 Q98216077-13F8EB6C-60B0-4101-872C-3E1229EE8B76 @default.
- Q98216077 P1476 Q98216077-BB72B8E7-B972-43CD-BE32-1A710451417D @default.
- Q98216077 P2093 Q98216077-10742D84-70F7-47DD-8F48-4D34A04EE0F6 @default.
- Q98216077 P2093 Q98216077-2AF4525B-A84C-4A3F-95A5-727503712255 @default.
- Q98216077 P2093 Q98216077-63B0433C-3059-427B-9938-A37E842AC166 @default.
- Q98216077 P2093 Q98216077-8F9637F4-0EA1-4D2E-9782-8C90D1416D2B @default.
- Q98216077 P2093 Q98216077-A64FDB45-ED4B-47E9-A4A4-D9CB66378C81 @default.
- Q98216077 P2093 Q98216077-C1172CB3-F287-425B-9E8D-FC67D7AC8183 @default.
- Q98216077 P2093 Q98216077-CE79927A-4B4B-4FD8-B176-88F5006F91CF @default.
- Q98216077 P2093 Q98216077-D2419507-1134-41E0-B989-BE10B5AD9CDB @default.
- Q98216077 P304 Q98216077-F366E744-5CE7-4138-A180-B1206C26A59A @default.
- Q98216077 P31 Q98216077-882ECD19-F44F-4D09-A315-794E01A875A0 @default.
- Q98216077 P433 Q98216077-AA719DE4-1C82-464F-AA21-6042593BAD7E @default.
- Q98216077 P478 Q98216077-71A73F77-B84A-4FC5-930C-153DF6C72237 @default.
- Q98216077 P577 Q98216077-323EAF28-229A-4312-B303-851599967492 @default.
- Q98216077 P698 Q98216077-0D88F6E1-4E55-4B2C-A49C-9734FBA11999 @default.
- Q98216077 P698 32758339 @default.
- Q98216077 P1433 Q5274419 @default.
- Q98216077 P1476 "Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction" @default.
- Q98216077 P2093 "Fengli Zhang" @default.
- Q98216077 P2093 "Mei Zhang" @default.
- Q98216077 P2093 "Ping Li" @default.
- Q98216077 P2093 "Tiantian Ni" @default.
- Q98216077 P2093 "Wanghao Kuang" @default.
- Q98216077 P2093 "Xin Sun" @default.
- Q98216077 P2093 "Yanfen Yin" @default.
- Q98216077 P2093 "Zhou Zhou" @default.
- Q98216077 P304 "389-394" @default.
- Q98216077 P31 Q13442814 @default.
- Q98216077 P433 "8" @default.
- Q98216077 P478 "75" @default.
- Q98216077 P577 "2020-08-01T00:00:00Z" @default.
- Q98216077 P698 "32758339" @default.